HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tahseen Mozaffar Selected Research

eculizumab

12/2021Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab: subgroup analysis of REGAIN and its extension study.
1/2021Long-term efficacy of eculizumab in refractory generalized myasthenia gravis: responder analyses.
7/2013A randomized, double-blind, placebo-controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tahseen Mozaffar Research Topics

Disease

16Myasthenia Gravis
11/2023 - 03/2010
11Glycogen Storage Disease Type II (Pompe's Disease)
02/2024 - 01/2015
11Muscular Diseases (Myopathy)
04/2023 - 01/2007
10Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
04/2024 - 12/2007
6Frontotemporal Dementia (Semantic Dementia)
01/2022 - 01/2012
5Muscle Weakness
11/2023 - 02/2013
5Osteitis Deformans (Paget's Disease of Bone)
01/2022 - 01/2012
4Inclusion Body Myositis
10/2023 - 07/2018
4Demyelinating Diseases (Demyelinating Disease)
09/2015 - 11/2007
4Wounds and Injuries (Trauma)
06/2014 - 04/2005
3Proteostasis Deficiencies
01/2023 - 08/2015
3Autoimmune Diseases (Autoimmune Disease)
01/2023 - 01/2021
3Disease Progression
01/2022 - 01/2018
3Inclusion Body Myopathy With Early-Onset Paget Disease And Frontotemporal Dementia
01/2021 - 01/2012
3Nonaka type Distal myopathy
03/2014 - 01/2012
2Neuroinflammatory Diseases
04/2024 - 01/2022
2Thymoma (Thymic Carcinoma)
11/2023 - 11/2020
2Neuromuscular Diseases (Neuromuscular Disease)
01/2022 - 12/2018
2Dementia (Dementias)
01/2022 - 01/2019
2Muscular Atrophy (Muscle Atrophy)
07/2018 - 01/2007
2Body Weight (Weight, Body)
03/2015 - 01/2007
2Hypoxia (Hypoxemia)
06/2014 - 07/2012
1Clostridium Infections
11/2023
1Respiratory Insufficiency (Respiratory Failure)
11/2023
1Interstitial Nephritis (Tubulointerstitial Nephritis)
10/2023
1Inflammation (Inflammations)
03/2023
1Inborn Genetic Diseases (Disease, Hereditary)
01/2023
1Bone Diseases (Bone Disease)
01/2023
1Neoplasms (Cancer)
01/2023
1Cardiomyopathies (Cardiomyopathy)
01/2022
1Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy)
01/2022
1Movement Disorders (Movement Disorder)
01/2022
1Parkinsonian Disorders (Parkinsonism)
01/2022
1Anaphylaxis (Anaphylactic Shock)
12/2021
1Headache (Headaches)
12/2021
1Myocardial Infarction
12/2021
1Nasopharyngitis
12/2021
1Arthralgia (Joint Pain)
12/2021
1Stroke (Strokes)
12/2021
1Myalgia
12/2021
1Dermatomyositis (Dermatopolymyositis)
04/2021
1Myositis (Idiopathic Inflammatory Myopathies)
01/2021
1Eosinophilia
01/2021
1Fibrosis (Cirrhosis)
01/2021
1Arhinia, choanal atresia, and microphthalmia
10/2019
1Facioscapulohumeral Muscular Dystrophy
10/2019

Drug/Important Bio-Agent (IBA)

9Valosin Containing ProteinIBA
10/2023 - 01/2012
7Biomarkers (Surrogate Marker)IBA
04/2024 - 06/2014
7Cholinergic ReceptorsIBA
11/2023 - 07/2013
6glucose-mannose-glucoseIBA
11/2023 - 01/2019
6GlycogenIBA
11/2023 - 01/2016
6AcidsIBA
11/2022 - 01/2017
5Proteins (Proteins, Gene)FDA Link
03/2023 - 09/2015
5human GAA protein (Myozyme)FDA Link
12/2021 - 01/2015
4GlucosidasesIBA
11/2023 - 01/2017
4AutoantibodiesIBA
01/2023 - 01/2019
3miglustat (Zavesca)FDA Link
02/2024 - 12/2021
3Adrenal Cortex Hormones (Corticosteroids)IBA
01/2023 - 03/2010
3EnzymesIBA
12/2021 - 07/2019
3eculizumabFDA Link
12/2021 - 07/2013
3Prednisone (Sone)FDA LinkGeneric
11/2020 - 11/2016
2Immunoglobulins (Immunoglobulin)IBA
01/2023 - 01/2019
2alpha-Glucosidases (Acid Maltase)IBA
11/2022 - 07/2019
2N-Acetylneuraminic Acid (Sialic Acid)IBA
01/2022 - 01/2019
2margatoxinIBA
11/2020 - 01/2019
2Neuroprotective AgentsIBA
01/2019 - 12/2007
2LipidsIBA
03/2014 - 05/2008
2IntegrinsIBA
07/2012 - 04/2010
1arimoclomolIBA
10/2023
1Galectin 3 (LGALS3)IBA
04/2023
1RNA (Ribonucleic Acid)IBA
01/2023
1Chimeric Antigen ReceptorsIBA
01/2023
1B-Cell Maturation AntigenIBA
01/2023
1bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
01/2023
1DNA (Deoxyribonucleic Acid)IBA
01/2023
1Nerve Growth Factors (Neurotrophins)IBA
01/2022
1LectinsIBA
01/2022
1Rituximab (Mabthera)FDA Link
12/2021
1Creatine Kinase (Creatine Phosphokinase)IBA
12/2021
1Immunoglobulin G (IgG)IBA
11/2021
1bazlitoranIBA
04/2021
1Toll-Like Receptor 7IBA
04/2021
1Interleukin-33IBA
01/2021
1Interleukin-2 (IL2)IBA
01/2021
15'-Nucleotidase (5' Nucleotidase)IBA
01/2021
1Interleukin-5 (Interleukin 5)IBA
01/2021
1CreatinineIBA
01/2020
1Complement Inactivating AgentsIBA
01/2020
1zilucoplanIBA
01/2020
1myotubularinIBA
10/2019
1Adenosine Triphosphatases (ATPase)IBA
10/2019

Therapy/Procedure

13Therapeutics
02/2024 - 03/2018
6Activities of Daily Living (ADL)
11/2023 - 07/2016
4Thymectomy
11/2020 - 11/2016
3Enzyme Replacement Therapy
11/2023 - 12/2021
2Bioreactors (Bioreactor)
09/2015 - 07/2012
1Occupational Therapy (Therapy, Occupational)
01/2022
1Cell- and Tissue-Based Therapy (Cell Therapy)
01/2022
1Physical Therapy Modalities (Physical Therapy Technique)
01/2022
1Investigational Therapies (Experimental Therapy)
11/2020